Gb Sciences Stock Operating Margin
GBLX Stock | USD 0.01 0 33.00% |
GB Sciences fundamentals help investors to digest information that contributes to GB Sciences' financial success or failures. It also enables traders to predict the movement of GBLX Pink Sheet. The fundamental analysis module provides a way to measure GB Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to GB Sciences pink sheet.
GBLX |
GBLX Operating Margin Analysis
GB Sciences' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition |
Based on the recorded statements, GB Sciences has an Operating Margin of 0.0%. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The operating margin for all United States stocks is 100.0% lower than that of the firm.
GBLX Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses GB Sciences' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of GB Sciences could also be used in its relative valuation, which is a method of valuing GB Sciences by comparing valuation metrics of similar companies.GB Sciences is currently under evaluation in operating margin category among related companies.
GBLX Fundamentals
Return On Equity | -50.98 | |||
Return On Asset | -0.21 | |||
Current Valuation | 10.19 M | |||
Shares Outstanding | 379.21 M | |||
Shares Owned By Insiders | 13.08 % | |||
Price To Earning | 4.04 X | |||
Price To Book | 1.08 X | |||
Price To Sales | 1.91 X | |||
Gross Profit | (881.46 K) | |||
EBITDA | 398.73 K | |||
Net Income | (530.87 K) | |||
Cash And Equivalents | 53.96 K | |||
Total Debt | 397.31 K | |||
Debt To Equity | 1.07 % | |||
Current Ratio | 0.03 X | |||
Book Value Per Share | (0) X | |||
Cash Flow From Operations | (1.87 M) | |||
Beta | 0.56 | |||
Market Capitalization | 8.21 M | |||
Total Asset | 2.55 M | |||
Retained Earnings | (78.28 M) | |||
Working Capital | 881 K | |||
Current Asset | 2.2 M | |||
Current Liabilities | 1.32 M | |||
Z Score | -30.0 | |||
Net Asset | 2.55 M |
About GB Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze GB Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of GB Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of GB Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.GB Sciences, Inc. engages in the research and development of plant-based medicines in North America and Europe. GB Sciences, Inc. was incorporated in 2001 and is based in Las Vegas, Nevada. Growblox Sciences operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 3 people.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out GB Sciences Piotroski F Score and GB Sciences Altman Z Score analysis. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for GBLX Pink Sheet analysis
When running GB Sciences' price analysis, check to measure GB Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GB Sciences is operating at the current time. Most of GB Sciences' value examination focuses on studying past and present price action to predict the probability of GB Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GB Sciences' price. Additionally, you may evaluate how the addition of GB Sciences to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |